Sirtris’ drugs candidates modulate the sirtuins, a recently discovered class of enzymes involved in the aging process.

News Coverage

The following is a selection of news stories in which Sirtris is featured. 

• March/April 2010, Technology Review, "TR50:  Technology Review’s Most Innovative Companies"
• February 11, 2010, Time, "Longevity Drugs May be Coming"
• November 19, 2009, Scrip News, "2009 Scrip Awards celebrate industry's achievements"
• November 4, 2009, Mass High Tech, "Success in a Biotech Launch Starts with a Great Team"
• November 4, 2009, NECN, Business:  Christoph Westphal, CEO of Sirtris
• October 10, 2009, Boston Globe, “Age-old woes, new tactic”
• September 29, 2009, New York Times, “Quest for a Long Life Gains Scientific Respect”
• August 19, 2009, New York Times, “Tests Begin on Drugs That May Slow Aging”
• April 2009, Forbes/Wolfe Emerging Tech Report, “Christoph Westphal: Finding the Fountain of Youth”
• April 23, 2009, CNN, Vital Signs with Dr. Sanjay Gupta, “Unlocking the Secrets of Aging”
• January 25, 2009, 60 Minutes, “Wine Rx”
• December 15, 2008, Newsweek, “Never Say Die”
• September 16, 2008, Discover, “Is Wine What Flows Through the Fountain of Youth?”
• July 22, 2008, New York Times, “Hoping Two Drugs Carry a Side Effect:  Longer Life”
• April 24, 2008, BioWorld Today, “GSK Grabbing Sirtuin Platform with $720M Sirtris Acquisition”
• April 1, 2008, Barbara Walters, “Live to 150, Can You Do It?”
• Current Opinion in Investigational Drugs, 2008 Vol 9 No 4, “Sirtuins: Novel targets for metabolic disease”
• February 23, 2007, Fortune, “Drink Wine and Live Longer”
• March 2006, Scientific American, “Unlocking the Secrets of Longevity Genes”

Sirtris Resources

+

+Mouse Marathon Video The mouse on the right, treated with resveratrol, ran nearly twice as long as the mouse on the left.

Contact Information

For media inquiries, please visit the GSK media contacts page.